Gene Query: UAP1

Dataset Description Geneva Score
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 83.89
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 83.89
Role for citron kinase in prostate cancer growth 72.77
Silencing SPIB in attached and floating state of H1703 lung cancer cells 63.69
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 57.45
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 56.78
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 53.44
RNA-seq of young and quiescent MRC-5 human fibroblasts 52.17
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 51.44
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 51.44
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 50.94
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 50.94
Differential analysis of gene regulation at transcript resolution by RNA-Seq 48.24
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 48.24
Ebola virus (EBOV) infection of ARPE-19 cells 46.5
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 45.73
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 44.55
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 44.11
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 42.62
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 41.45
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 41.38
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 41.38
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 41.27
IL-33 activates tumor stroma to promote intestinal polyposis 38.8
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 38.67
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 38.67
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 38.53
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 35.0
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 32.64
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 32.64
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 32.28
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 32.28
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 32.19
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 31.76
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 31.69
RNA-sequencing of human tendon after injury 31.16
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 30.99
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 30.9
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 30.58
Paxillin regulates genomic networks in prostate cancer [LNCaP] 30.53
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 29.81
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 29.21
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 29.18
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 29.15
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 29.02
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 28.63
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 28.39
Gene expression analysis of dengue-infected cells 27.57
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 27.46
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 27.46
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 26.62
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 26.31
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 26.31
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 26.3
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 25.59
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 25.48
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 25.4
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 25.38
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 25.35
METTL3 promotes translation in human cancer cells 25.12
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 24.7
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 24.11
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 23.74
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 23.68
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 23.37
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 23.37
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 23.24
Differential gene expression in Jagged1 treated human dental pulp cells. 22.82
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 22.79
Transcriptome of U251 cells overexpression complement component 7 22.49
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 22.34
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 22.19
Gene expression profiling of human and murine in vitro muscle differentiation 22.11
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 21.65
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 21.33
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 21.32
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 21.2
Noncoding regions are the main source of targetable tumor-specific antigens 21.16
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 21.07
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 21.03
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 20.75
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 20.67
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 20.4
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 19.84
Differentially expressed genes post knock down of lincDUSP26 19.71
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 19.66
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 19.53
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 19.53
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 19.31
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 19.31
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 19.24
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 19.09
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 19.07
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 18.86
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 18.56
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 18.39
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 18.37
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 18.09
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 18.06
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 18.02
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 17.8
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 17.78
Differential gene expression profiles in imatinib-resistant cell lines 17.74
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 17.71
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 17.67
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 17.32
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 17.21
Tumor exosome integrins determine organotropic metastasis 17.15
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 17.13
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 17.06
Transcriptomic and gene ontology profiling of the human corneal cell types 16.96
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 16.85
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 16.74
Ribosomal footprinting of CN34-Parental and CN34-LM1a 16.71
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 16.65
A prostate cancer chromatin interaction map 16.59
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 16.45
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 16.36
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 16.2
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 16.09
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 15.95
High level DNA repair gene expression in human ES cells 15.89
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 15.86
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 15.86
Dtx3L and Androgen Signaling in Prostate Cancer 15.81
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 15.63
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 15.54
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 15.54
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 15.48
MYCi975 regulates MYC target genes 15.48
Ribosomal footprinting of MDA-Parental and MDA-LM2 15.48
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 14.94
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 14.87
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 14.79
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 14.73
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 14.65
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 14.56
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 14.51
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 14.34
Splicing and epigenetic factors jointly regulate epidermal differentiation 14.21
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 14.21
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 14.2
RNA-seq of human aneuploid cell lines with Trisomy 21 14.14
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 14.12
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 14.11
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 14.05
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 13.96
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 13.93
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 13.89
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 13.88
BAF controls genome accessibility 13.77
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 13.75
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 13.65
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 13.48
MYCi361 regulates MYC target genes 13.41
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 13.4
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 13.37
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 13.36
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 13.33
Transcriptome profiling of 5 human adenocarcinoma cell lines 13.33
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 13.3
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 13.27
EWSR1 influences alternative splicing through direct and indirect mechanisms 13.25
RNA-seq analysis of BAP1-depleted uveal melanoma cells 13.05
Characterization of human ILC2 subsets 12.88
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.85
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 12.76
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 12.75
GATA3-mediated chromatin reprogramming in breast cancer cells 12.62
Statins modulate endothelial transcriptional profile by inhibiting EZH2 12.58
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 12.58
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 12.57
In vitro modeling of human germ cell development using pluripotent stem cells 12.56
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 12.46
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 12.17
PGE2 mediated gene expression changes in human cervical stromal cells 12.15
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 12.11
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 12.11
Cajal bodies are linked to genome conformation [RNA-Seq] 12.0
Cajal bodies are linked to genome conformation 12.0
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 11.96
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 11.96
Differetially expressed genes after hTR overexpression in U2OS cells 11.93
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 11.83
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 11.79
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 11.77
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.77
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 11.7
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 11.62
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 11.6
Tracking distinct RNA populations using efficient and reversible covalent chemistry 11.54
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 11.54
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 11.51
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 11.43
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 11.41
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 11.41
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 11.4
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 11.39
AR-independent prostate cancer is sustained through FGF signaling 11.29
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 11.22
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.22
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 11.2
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 11.2
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 11.15
Transcriptome of activated human and mouse MAIT cells 11.12
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 11.11
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 11.08
DJ-1 is dispensable for human stem cell homeostasis 11.06
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 10.99
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 10.92
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.86
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 10.85
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 10.83
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 10.75
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 10.75
Seletive inhibition of CDK9 in DLBCL cell lines 10.73
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 10.63
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 10.56
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 10.55
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.55
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 10.52
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 10.51
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 10.51
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 10.5
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 10.48
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 10.48
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 10.48
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 10.48
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 10.47
The pause-initiation limit restricts transcription activation in human cells 10.44
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 10.43
RNA-seq analysis of AML cells in response to ASLAN003 10.4
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 10.4
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 10.37
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 10.31
Expression by CD133+ cells isolated from the adult human exocrine pancreas 10.29
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 10.28
Effect of mitochondria deficiency on senescence-associated gene expression 10.27
Transcriptome analysis of U87 cells upon LINC00152 knockdown 10.27
CDK12 mediated transcriptional regulation in U2OS cells 10.21
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.21
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 10.16
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 10.03
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 10.03
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 10.01
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 9.95
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 9.92
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 9.91
Neonatal and adult human testis defined at the single-cell level 9.88
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.87
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 9.84
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 9.79
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 9.78
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 9.77
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 9.74
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 9.74
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 9.67
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 9.63
Effect of BB608 on Gene Expression in HNSCC Cell Line 9.62
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 9.62
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 9.62
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 9.59
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 9.55
RNA sequencing of primary human platelets and in vitro cell lines 9.5
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.48
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 9.48
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 9.48
mRNA differential expression analysis in a human ex vivo model of chronic wounds 9.48
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 9.46
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 9.45
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.38
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 9.3
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 9.29
Selective suppression of endothelial cytokine production by progesterone receptor 9.28
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 9.28
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 9.25
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 9.16
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 9.16
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 9.12
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 9.04
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 9.03
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 9.03
Gene profiling of human adult and pediatric liver cancer cells 8.98
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 8.95
Biological effect of chronic mistranslation in mammalian cells 8.93
Genome-wide discovery of human splicing branchpoints 8.92
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 8.88
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.8
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.75
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 8.73
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 8.71
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.69
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.69
TGF-β regulation of miRNA expression in pancreatic cancer 8.65
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 8.61
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 8.61
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 8.57
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 8.52
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 8.48
Lipid degradation promotes prostate cancer cell survival 8.36
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 8.29
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 8.22
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 8.19
Cell responses to dysregulated VZV-induced cell-cell fusion 8.16
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.03
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 7.97
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 7.95
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 7.9
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 7.87
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 7.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 7.82
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 7.74
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.72
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 7.67
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.61
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 7.53
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 7.52
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 7.46
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.43
ETV7 and interferon response 7.39
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.39
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 7.35
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 7.35
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 7.35
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.35
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 7.34
Genome-wide discovery of human splicing branchpoints [RNAse] 7.28
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 7.27
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 7.25
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 7.23
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 7.13
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 7.06
The Genomic Landscape of Atypical Fibroxanthoma 7.02
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 6.94
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 6.94
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 6.85
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 6.85
Gene Expression Profiling of SPOP Knocked Down Cell 6.79
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 6.76
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.7
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 6.7
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 6.65
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 6.63
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 6.63
Identification of Sin3B regulated genes during quiescence 6.55
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.44
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 6.28
Identification of global XBP1s target gene expression in human prostate cancer cells 6.24
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.2
Positively selected enhancer elements endow tumor cells with metastatic competence 6.13
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 6.06
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 6.06
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 6.0
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 6.0
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 6.0
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.89
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.89
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 5.87
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 5.8
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.75
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 5.7
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.68
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.68
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 5.64
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 5.6
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.55
Transcriptome analysis reveals differential splicing events in IPF lung tissue 5.53
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 5.48
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 5.4
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 5.34
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.32
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.32
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 5.31
RNA-sequencing 5.24
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 5.23
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 5.19
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.16
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 5.13
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.12
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 5.03
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 5.01
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 4.99
The cohesin complex prevents Myc-induced replication stress 4.86
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 4.69
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.59
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.55
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.52
Oncogenic roles of ARID5B in T-ALL 4.51
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 4.51
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.49
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.49
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.32
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 4.24
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.24
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.18
Gene expression profile of multiple myeloma cell lines treated with CB-5083 4.16
Expression patterns in chronic thromboembolic pulmonary hypertension 4.13
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.1
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 4.06
Regulatory network controlling tumor-promoting inflammation in human cancers 4.06
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.04
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.03
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.87
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 3.85
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.78
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.78
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.78
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 3.73
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 3.68
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 3.66
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 3.53
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 3.53
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 3.47
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 3.47
An optimization system for isolating and sequencing of single human colon cancer cells 3.44
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 3.38
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 3.37
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 3.34
miR-93 Targets in Human Endothelial Cells 3.22
Gene expression profile of CRC-derived HILEC 3.15
Age-Related Gene Expression Changes in Prostate Cancer Patients 3.09
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 3.09
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.06
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 3.0
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.94
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.92
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.77
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.58
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 2.58
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 2.58
CSL 2.53
CSL RNA-Seq on HKC and SCC cell lines 2.53
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.51
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.51
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.51
siRNA-mediated knockdown 2.48
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 2.48
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 2.46
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.46
FOXP2's impact on the primate transcriptome 2.41
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.36
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.3
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.27
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 2.26
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.25
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.25
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.22
RNA-Seq of Breast and Ovarian Cancer Cell Lines 2.15
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 2.13
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.07
ARID1A and ARID1B loss in HCT116 cells 2.05
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.01
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.99
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.96
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.96
Measure transcript integrity using RNA-seq data 1.95
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.92
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.85
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.82
Identification of differentially expressed genes between senescence and senescence bypass cells 1.73
MAIT cell RNA sequencing 1.72
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.55
Generation of KRAS signatures using immortalized isogenic lung cells. 1.49
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.49
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  1.41
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 1.41
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.37
Random mono-allelic expression in MECP2-mutated cells 1.36
Gene expression profiling of KSHV-infected periodontal ligament cells 1.36
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 1.33
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 1.33
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.32
NHLRC1 re-expression in cancer cells 1.31
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.24
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.19
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.18
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.03
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.01
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.96
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.91
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.81
Modulation of nonsense-mediated decay by rapamycin 0.81
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 0.79
Exogenous rescue of KLHL9 in SF210 cell line 0.72
Genome-wide transcriptional response to random aneuploidy in human cells 0.59
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.58
DRB/GRO-Seq -/+ UV 0.53
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 0.48
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.46
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.44
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.41
RNA-seq of IL-4 stimulated human keratinocytes 0.37
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.33
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.33
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 0.22
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.16
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.14
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.14
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.12
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation